☆ 4.3 Article

Expression of B7-H3 and TIM-3 in gastric-type endocervical adenocarcinoma: prevalence, association with PD-L1 expression, and prognostic significance

JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Gastric-Type Adenocarcinoma of the Uterine Cervix Associated with Poor Response to Definitive Radiotherapy

Airi Kuruma et al.

Summary: Cervical cancer is the most common gynecological malignancy. The incidence of adenocarcinoma has increased in some countries recently, especially in the young population. Our study found that adenocarcinoma patients had a lower response to definitive radiotherapy and shorter survival times compared to squamous cell carcinoma patients.

CANCERS (2023)

添加到收藏夹

Article Pathology

Assessment of HER2 in Gastric-Type Endocervical Adenocarcinoma and its Prognostic Significance

Su Wang et al.

MODERN PATHOLOGY (2023)

添加到收藏夹

Article Pathology

Discordance of PD-L1 expression in primary and metastatic ovarian high-grade serous carcinoma and its correlation with CD8+tumor-infiltrating lymphocytes and patient prognosis

Tao Zhang et al.

Summary: The expression of PD-L1 in primary and metastatic ovarian HGSC and its correlation with CD8+ TILs and patient survival were investigated. PD-L1 expression showed significant discordance between ovarian and omental tumors. Patients with PD-L1-positive tumors had worse recurrence free survival and overall survival. However, high CD8 TILs density was not associated with worse survival.

VIRCHOWS ARCHIV (2023)

添加到收藏夹

Review Oncology

Targeting the immune checkpoint B7-H3 for next-generation cancer immunotherapy

Chuan Liu et al.

Summary: This review discusses the recent results of clinical trials evaluating the antitumor activity and safety of B7-H3 targeting drugs, as well as the challenges and opportunities arising from their application in cancer treatment. Current gaps in understanding the function and regulation of B7-H3 are pointed out as crucial for unleashing the full clinical utility of B7-H3-based therapies.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)

添加到收藏夹

Article Pathology

Expression of B7 family checkpoint proteins in cervical cancer

Liju Zong et al.

Summary: The study investigated the expression of PD-L1, B7-H3, B7-H4, and VISTA in cervical cancer and their associations with clinicopathological features and outcomes. Different expression patterns and prognostic implications were observed, with B7-H4 and VISTA in ICs showing more frequent expression and being correlated with improved survival. The co-expression of PD-L1 with other checkpoint proteins suggests a potential novel therapeutic approach for cervical cancer.

MODERN PATHOLOGY (2022)

添加到收藏夹

Article Cell Biology

Programmed death-ligand 1 expression in human papillomavirus-independent cervical adenocarcinoma and its prognostic significance

Lili Chen et al.

Summary: This study aimed to investigate PD-L1 expression in different types of endocervical adenocarcinomas and compare their prognostic value, revealing frequent PD-L1 expression in both HPVI ECA and HPVA ECA, with PD-L1 serving as a negative prognostic marker for GEAs.

HISTOPATHOLOGY (2022)

添加到收藏夹

Article Pathology

Prevalence and prognostic significance of PD-L1, TIM-3 and B7-H3 expression in endometrial serous carcinoma

Hao Chen et al.

Summary: Endometrial serous carcinoma (ESC) patients may benefit from immune checkpoint blockade therapy targeting PD-L1, TIM-3, and B7-H3. PD-L1 expression is correlated with higher CD8 + T-cell density and improved overall survival.

MODERN PATHOLOGY (2022)

添加到收藏夹

Article Oncology

Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade

Fei Ju et al.

Summary: This study investigated the impact of PD-1 inhibitor-armed oncolytic viruses on the tumor microenvironment. The results suggest that localized delivery of PD-1 inhibitors by engineered oncolytic viruses is an effective and safe approach for cancer immunotherapy, with potential synergies with other immune checkpoint inhibitors.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

添加到收藏夹

Article Oncology

Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic drivers

Sarah Ehmann et al.

Summary: Gastric-type endocervical adenocarcinoma (GEA) is a rare form of cervical cancer not associated with HPV infection. It is aggressive with poor progression-free survival (PFS) and overall survival (OS). Further investigation is needed to identify the optimal management approach for this rare subtype.

GYNECOLOGIC ONCOLOGY (2022)

添加到收藏夹

Article Pathology

PD-L1 Expression in Endocervical Adenocarcinoma Correlation With Patterns of Tumor Invasion, CD8+ Tumor-infiltrating Lymphocytes, and Clinical Outcomes

Glorimar Rivera-Colon et al.

Summary: This study found frequent PD-L1 expression in ECA with destructive-type invasion, particularly in tumors with higher expression. PD-L1-positive ECAs showed higher CD8(+) tumor-infiltrating lymphocyte density and worse progression-free survival compared to PD-L1-negative ECAs. In conclusion, PD-L1 may serve as a therapeutic target for ECA with destructive-type invasion and as a negative prognostic marker associated with unfavorable outcomes.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)

添加到收藏夹

Review Oncology

TIM-3 as a Prognostic Marker and a Potential Immunotherapy Target in Human Malignant Tumors: A Meta-Analysis and Bioinformatics Validation

Kui Zang et al.

Summary: TIM-3 was identified as an independent adverse prognostic indicator for overall survival in various types of cancer. It plays a crucial role in tumor immune responses, supporting its potential as a promising target for cancer immunotherapy.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Phase I/Ib Clinical Trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti-PD-1 Antibody, in Advanced Solid Tumors

Giuseppe Curigliano et al.

Summary: The study aimed to evaluate the safety and efficacy of Sabatolimab and spartalizumab in patients with advanced solid tumors. The results showed that the combination of Sabatolimab plus spartalizumab was well tolerated and showed signs of antitumor activity, with the recommended dose for Sabatolimab being 800 mg Q4W, with or without 400 mg spartalizumab Q4W.

CLINICAL CANCER RESEARCH (2021)

添加到收藏夹

Article Immunology

Targeting STAT3 Abrogates Tim-3 Upregulation of Adaptive Resistance to PD-1 Blockade on Regulatory T Cells of Melanoma

Lili Huang et al.

Summary: This study evaluates the changes in the tumor microenvironment (TME) after PD-1 blockade, focusing on the role of Treg cells and the expression of Tim-3. Targeting STAT3 in melanoma models can significantly enhance the response to PD-1 therapy by reducing immunosuppression mediated by Treg cells. These findings support STAT3 as a potential target for improving immunotherapy efficacy in melanoma patients.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Oncology

The Role of CD276 in Cancers

Shengzhuo Liu et al.

Summary: CD276 plays a crucial role in cell proliferation, invasion, and migration in malignancies. Recent studies suggest that CD276 could be a promising therapeutic target for malignant tumors. The review comprehensively describes the role of CD276 in malignancies and its potential therapeutic effect.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Oncology

PD-L1 expression in tumor cells is associated with a favorable prognosis in patients with high-risk endometrial cancer

Liju Zong et al.

Summary: The expression patterns of PD-L1 in tumor cells and immune cells, as well as their associations with different molecular subtypes, may play a significant role in selecting patients eligible for endometrial cancer immunotherapy.

GYNECOLOGIC ONCOLOGY (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Expression of B7-H3 Correlates with PD-L1 and Poor Prognosis in Patients with Cervical Cancer

Qianqian Zhang et al.

Summary: The study investigated the expression of B7 homolog 3 (B7-H3) in cervical cancer patients and its associations with programmed cell-death ligand 1 (PD-L1), pathological features, and survival. B7-H3 expression in tumor cells was found to be associated with squamous cell carcinoma, PD-L1 positivity, lymph node metastasis, and shorter survival, suggesting it as a promising prognostic biomarker for targeting in immunotherapeutic strategies.

ONCOTARGETS AND THERAPY (2021)

添加到收藏夹

Review Immunology

B7-H3/CD276: An Emerging Cancer Immunotherapy

Wu-Tong Zhou et al.

Summary: B7-H3 protein, overexpressed in tumor tissues and showing limited expression in normal tissues, is a promising target for cancer immunotherapy due to its involvement in tumor microenvironment shaping and development. Numerous B7-H3-based immunotherapy strategies have demonstrated potent antitumor activity and acceptable safety profiles in preclinical models.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Oncology

Targeting Tim-3 in Cancer With Resistance to PD-1/PD-L1 Blockade

Tian Tian et al.

Summary: Blocking therapy targeting programmed death receptor 1 (PD-1) or programmed death ligand 1 (PD-L1) has revolutionized the treatment of malignant tumors, but patient response rates are low and drug resistance is a major concern. Combining this therapy with Tim-3 blockade may offer a promising approach to overcoming resistance in cancer immunotherapy.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Pathology

Looking past PD-L1: expression of immune checkpoint TIM-3 and its ligand galectin-9 in cervical and vulvar squamous neoplasia

Jacob Curley et al.

MODERN PATHOLOGY (2020)

添加到收藏夹

Article Pathology

PD-L1 Expression and CD8+ Tumor-infiltrating Lymphocytes in Different Types of Tubo-Ovarian Carcinoma and Their Prognostic Value in High-grade Serous Carcinoma

Hao Chen et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)

添加到收藏夹

Review Cell Biology

Immune checkpoint signaling and cancer immunotherapy

Xing He et al.

CELL RESEARCH (2020)

添加到收藏夹

Article Immunology

Expression and Significance of Immune Checkpoints in Clear Cell Carcinoma of the Uterine Cervix

Liju Zong et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2020)

添加到收藏夹

Article Oncology

Dual but not single PD-1 or TIM-3 blockade enhances oncolytic virotherapy in refractory lung cancer

Fan Sun et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

添加到收藏夹

Review Oncology

Prognostic Values of TIM-3 Expression in Patients With Solid Tumors: A Meta-Analysis and Database Evaluation

Shuang Qin et al.

FRONTIERS IN ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Analysis of gastric-type mucinous carcinoma of the uterine cervix - An aggressive tumor with a poor prognosis: A multi-institutional study

Shin Nishio et al.

GYNECOLOGIC ONCOLOGY (2019)

添加到收藏夹

Article Oncology

Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study

Hyun Cheol Chung et al.

JOURNAL OF CLINICAL ONCOLOGY (2019)

添加到收藏夹

Article Oncology

The impact of programmed cell death-ligand 1 (PD-L1) and CD8 expression in grade 3 endometrial carcinomas

Stylianos Vagios et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)

添加到收藏夹

Article Oncology

The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors

Andrew A. Davis et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)

添加到收藏夹

Article Genetics & Heredity

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Robert M. Samstein et al.

NATURE GENETICS (2019)

添加到收藏夹

Article Oncology

Chemoresistance of Gastric-Type Mucinous Carcinoma of the Uterine Cervix: A Study of the Sankai Gynecology Study Group

Atsumi Kojima et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2018)

添加到收藏夹

Article Pathology

International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix

Simona Stolnicu et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)

添加到收藏夹

Review Multidisciplinary Sciences

Cancer immunotherapy using checkpoint blockade

Antoni Ribas et al.

SCIENCE (2018)

添加到收藏夹

Article Oncology

Roles of B7-H3 in Cervical Cancer and Its Prognostic Value

Sai Han et al.

JOURNAL OF CANCER (2018)

添加到收藏夹

Article Obstetrics & Gynecology

Cancer of the cervix uteri

Neerja Bhatla et al.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2018)

添加到收藏夹

Review Oncology

Second- and third-generation drugs for immuno-oncology treatment-The more the better?

Wolfram C. M. Dempke et al.

EUROPEAN JOURNAL OF CANCER (2017)

添加到收藏夹

Review Immunology

Tim-3 and its role in regulating anti-tumor immunity

Madhumita Das et al.

IMMUNOLOGICAL REVIEWS (2017)

添加到收藏夹

Article Oncology

Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1-Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial

Jean-Sebastien Frenel et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

添加到收藏夹

Article Oncology

B7-H3 promotes the proliferation, migration and invasiveness of cervical cancer cells and is an indicator of poor prognosis

Yi Li et al.

ONCOLOGY REPORTS (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Resistance to checkpoint blockade therapy through inactivation of antigen presentation

Moshe Sade-Feldman et al.

NATURE COMMUNICATIONS (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy

Jianjun Gao et al.

CELL (2016)

添加到收藏夹

Article Oncology

B7-H3, B7-H4, Foxp3 and IL-2 expression in cervical cancer: Associations with patient outcome and clinical significance

Chenglin Huang et al.

ONCOLOGY REPORTS (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints

Shohei Koyama et al.

NATURE COMMUNICATIONS (2016)

添加到收藏夹

Article Pathology

Gastric-type Endocervical Adenocarcinoma An Aggressive Tumor With Unusual Metastatic Patterns and Poor Prognosis

Yevgeniy S. Karamurzin et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)

添加到收藏夹

Review Oncology

Classifying Cancers Based on T-cell Infiltration and PD-L1

Michele W. L. Teng et al.

CANCER RESEARCH (2015)

添加到收藏夹

Article Pathology

Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers

Louisa Mezache et al.

MODERN PATHOLOGY (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Roy S. Herbst et al.

NATURE (2014)

添加到收藏夹

Article Multidisciplinary Sciences

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Paul C. Tumeh et al.

NATURE (2014)

添加到收藏夹

Article Multidisciplinary Sciences

Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis

Yang Cao et al.

PLOS ONE (2013)

添加到收藏夹

Article Medicine, General & Internal

Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer

Suzanne L. Topalian et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

添加到收藏夹

Article Cell Biology

Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape

Janis M. Taube et al.

SCIENCE TRANSLATIONAL MEDICINE (2012)

添加到收藏夹

Review Oncology

The blockade of immune checkpoints in cancer immunotherapy

Drew M. Pardoll

NATURE REVIEWS CANCER (2012)

添加到收藏夹

Review Oncology

The immune contexture in human tumours: impact on clinical outcome

Wolf Herman Fridman et al.

NATURE REVIEWS CANCER (2012)

添加到收藏夹

Article Acoustics

Adenoma malignum of the uterine cervix: ultrasonographic findings in 11 patients

S. B. Park et al.

ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2011)

添加到收藏夹

Article Pathology

Absence of High-Risk Human Papillomavirus (HPV) Detection in Endocervical Adenocarcinoma with Gastric Morphology and Phenotype

Yasuki Kusanagi et al.

AMERICAN JOURNAL OF PATHOLOGY (2010)

添加到收藏夹

Review Immunology

B7-H3 and Its Role in Antitumor Immunity

Martin Loos et al.

CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2010)

添加到收藏夹

Article Immunology

TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines

William D. Hastings et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2009)

添加到收藏夹

Review Immunology

PD-1 and its ligands in tolerance and immunity

Mary E. Keir et al.

ANNUAL REVIEW OF IMMUNOLOGY (2008)

添加到收藏夹

Article Multidisciplinary Sciences

Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells

Ana C. Anderson et al.

SCIENCE (2007)

添加到收藏夹

Article Pathology

Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix

Atsumi Kojima et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)

添加到收藏夹

Article Immunology

Murine B7-H3 is a negative regulator of T cells

DVR Prasad et al.

JOURNAL OF IMMUNOLOGY (2004)

添加到收藏夹

Article Immunology

The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses

WK Suh et al.

NATURE IMMUNOLOGY (2003)

添加到收藏夹

Article Multidisciplinary Sciences

Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease

L Monney et al.

NATURE (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.